Published in Eur J Pain on April 01, 2005
Prescription opioid analgesics rapidly change the human brain. Pain (2011) 1.34
Response of the μ-opioid system to social rejection and acceptance. Mol Psychiatry (2013) 1.15
The contribution of the putamen to sensory aspects of pain: insights from structural connectivity and brain lesions. Brain (2011) 1.02
Measurement of central mu-opioid receptor binding in vivo with PET and [11C]carfentanil: a test-retest study in healthy subjects. Eur J Nucl Med Mol Imaging (2008) 0.88
A new biomarker of hedonic eating? A preliminary investigation of cortisol and nausea responses to acute opioid blockade. Appetite (2013) 0.88
Central poststroke pain: an abstruse outcome. Pain Res Manag (2008) 0.87
[Studies on cerebral processing of pain using functional imaging : Somatosensory, emotional, cognitive, autonomic and motor aspects]. Schmerz (2010) 0.87
Hypoalgesia associated with elevated resting blood pressure: evidence for endogenous opioid involvement. J Behav Med (2009) 0.83
Nystagmus secondary to drug exposure in utero. Br J Ophthalmol (2006) 0.82
Characterizing intercellular signaling peptides in drug addiction. Neuropharmacology (2008) 0.81
Analysis for distinctive activation patterns of pain and itchy in the human brain cortex measured using near infrared spectroscopy (NIRS). PLoS One (2013) 0.81
Thalamic metabolic alterations with cognitive dysfunction in idiopathic trigeminal neuralgia: a multivoxel spectroscopy study. Neuroradiology (2014) 0.79
Neuroimaging in cluster headache and other trigeminal autonomic cephalalgias. J Headache Pain (2011) 0.78
Deep brain stimulation of the periaqueductal gray releases endogenous opioids in humans. Neuroimage (2016) 0.77
Pain tolerance predicts human social network size. Sci Rep (2016) 0.75
Cerebral 5-HT release correlates with [(11)C]Cimbi36 PET measures of 5-HT2A receptor occupancy in the pig brain. J Cereb Blood Flow Metab (2016) 0.75
[Pain and consciousness. Articles from the summer workshop held by the German Interdisciplinary Collaboration for Pain Therapy (DIVS) in 2005]. Schmerz (2007) 0.75
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 13.23
Primary central nervous system lymphoma in a patient treated with natalizumab. Ann Neurol (2009) 6.96
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet (2013) 4.62
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflammation (2012) 3.12
Potassium channel KIR4.1 as an immune target in multiple sclerosis. N Engl J Med (2012) 2.90
An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis. Neuroimage (2011) 2.31
Distraction modulates connectivity of the cingulo-frontal cortex and the midbrain during pain--an fMRI analysis. Pain (2004) 2.20
Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis. Ann Neurol (2012) 2.15
Failure of natalizumab to prevent relapses in neuromyelitis optica. Arch Neurol (2012) 2.12
Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment. Neurology (2012) 1.94
The runner's high: opioidergic mechanisms in the human brain. Cereb Cortex (2008) 1.88
Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol (2013) 1.79
Central poststroke pain and reduced opioid receptor binding within pain processing circuitries: a [11C]diprenorphine PET study. Pain (2004) 1.77
Neuromyelitis optica following human papillomavirus vaccination. Neurology (2012) 1.44
Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica. Arch Neurol (2010) 1.35
Vowel sound extraction in anterior superior temporal cortex. Hum Brain Mapp (2006) 1.30
CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation. J Neuroinflammation (2012) 1.29
Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's disease. PLoS One (2012) 1.18
Subthalamic nucleus stimulation affects a frontotemporal network: a PET study. Ann Neurol (2003) 1.15
Frequency-correlated decreases of motor cortex activity associated with subthalamic nucleus stimulation in Parkinson's disease. Neuroimage (2005) 1.11
Hypothalamic deep brain stimulation in positron emission tomography. J Neurosci (2006) 1.10
SUNCT: bilateral hypothalamic activation during headache attacks and resolving of symptoms after trigeminal decompression. Pain (2005) 1.09
Transient receptor potential channel polymorphisms are associated with the somatosensory function in neuropathic pain patients. PLoS One (2011) 1.02
Left inferior parietal dominance in gesture imitation: an fMRI study. Neuropsychologia (2005) 1.02
The role of the cerebellum for predictive control of grasping. Cerebellum (2007) 1.01
HLA-DRB1*0401 and HLA-DRB1*0408 are strongly associated with the development of antibodies against interferon-beta therapy in multiple sclerosis. Am J Hum Genet (2008) 0.98
Opioidergic activation in the medial pain system after heat pain. Pain (2006) 0.98
Do physicians' recommendations pull patients away from their preferred treatment options? Health Expect (2011) 0.97
Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders. J Neuroinflammation (2011) 0.97
Neurofilament ELISA validation. J Immunol Methods (2009) 0.96
Cerebral metabolic dysfunction in patients with dementia with Lewy bodies and visual hallucinations. Dement Geriatr Cogn Disord (2008) 0.95
Multimodal motion processing in area V5/MT: evidence from an artificial class of audio-visual events. Brain Res (2008) 0.94
Repeated pain induces adaptations of intrinsic brain activity to reflect past and predict future pain. Neuroimage (2011) 0.94
An fMRI study on the acute effects of exercise on pain processing in trained athletes. Pain (2012) 0.94
Functional magnetic resonance imaging of the sensorimotor system in preterm infants. Pediatrics (2009) 0.93
Activities of daily living, cerebral glucose metabolism, and cognitive reserve in Lewy body and Parkinson's disease. Dement Geriatr Cogn Disord (2008) 0.91
COMT Val108/158Met genotype affects the mu-opioid receptor system in the human brain: evidence from ligand-binding, G-protein activation and preproenkephalin mRNA expression. Neuroimage (2005) 0.91
The role of lateral premotor-cerebellar-parietal circuits in motor sequence control: a parametric fMRI study. Brain Res Cogn Brain Res (2002) 0.91
White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI. Mult Scler (2013) 0.90
Spontaneous bilateral necrosis of the tongue: a manifestation of giant cell arteritis? Eur Arch Otorhinolaryngol (2008) 0.90
Syntheses, biological evaluation, and molecular modeling of 18F-labeled 4-anilidopiperidines as mu-opioid receptor imaging agents. J Med Chem (2005) 0.89
Why do some patients with schizophrenia want to be engaged in medical decision making and others do not? J Clin Psychiatry (2011) 0.87
High trait anxiety and hyporeactivity to stress of the dorsomedial prefrontal cortex: a combined phMRI and Fos study in rats. Neuroimage (2004) 0.87
The value of HMPAO SPECT in predicting treatment response to citalopram in patients with major depression. Psychiatry Res (2009) 0.86
Positron emission tomography ligand activation studies in the sports sciences: measuring neurochemistry in vivo. Methods (2008) 0.86
Kinetic modelling of [11C]flumazenil using data-driven methods. Eur J Nucl Med Mol Imaging (2008) 0.86
Dynorphins regulate fear memory: from mice to men. J Neurosci (2012) 0.85
Understanding neuropathic pain. CNS Spectr (2005) 0.85
Analgesia by electrostimulation of the trigeminal ganglion in patients with trigeminopathic pain: a PET activation study. Pain (2003) 0.84
Neurometabolic correlates of depression and disability in episodic cluster headache. J Neurol (2010) 0.84
Speciation analysis of selected metals and determination of their total contents in paired serum and cerebrospinal fluid samples: An approach to investigate the permeability of the human blood-cerebrospinal fluid-barrier. Anal Chim Acta (2008) 0.83
Fluoro-deoxy-glucose positron emission tomography correlates of impaired activities of daily living in dementia with Lewy bodies: implications for cognitive reserve. Am J Geriatr Psychiatry (2009) 0.83
Thyroid antibodies in aquaporin-4 antibody positive central nervous system autoimmunity and multiple sclerosis. Clin Endocrinol (Oxf) (2011) 0.81
Influence of the HLA-DRB1 genotype on antibody development to interferon beta in multiple sclerosis. Arch Neurol (2011) 0.81
Influence of 5-HTTLPR polymorphism on resting state perfusion in patients with major depression. J Psychiatr Res (2010) 0.80
Manganese species from human serum, cerebrospinal fluid analyzed by size exclusion chromatography-, capillary electrophoresis coupled to inductively coupled plasma mass spectrometry. J Trace Elem Med Biol (2007) 0.80
Abnormal movement preparation in task-specific focal hand dystonia. PLoS One (2013) 0.80
Metabolic correlates of brain reserve in dementia with Lewy bodies: an FDG PET study. Dement Geriatr Cogn Disord (2007) 0.80
Manganese speciation in human cerebrospinal fluid using CZE coupled to inductively coupled plasma MS. Electrophoresis (2007) 0.79
Should we measure the bioavailability of interferon beta in vivo in patients with multiple sclerosis? Nat Clin Pract Neurol (2009) 0.79
Towards NR2B receptor selective imaging agents for PET-synthesis and evaluation of N-[11C]-(2-methoxy)benzyl (E)-styrene-, 2-naphthyl- and 4-trifluoromethoxyphenylamidine. Bioorg Med Chem (2006) 0.79
Working memory in preterm-born adults: load-dependent compensatory activity of the posterior default mode network. Hum Brain Mapp (2014) 0.79
Right prefrontal hypometabolism predicts delusions in dementia with Lewy bodies. Neurobiol Aging (2008) 0.79
Can psychiatrists and neurologists predict their patients' participation preferences? J Nerv Ment Dis (2010) 0.79
Novel SCARB2 mutation in action myoclonus-renal failure syndrome and evaluation of SCARB2 mutations in isolated AMRF features. BMC Neurol (2011) 0.78
Quantification of [18F]diprenorphine kinetics in the human brain with compartmental and non-compartmental modeling approaches. Neuroimage (2004) 0.78
Selenium speciation in paired serum and cerebrospinal fluid samples. Anal Bioanal Chem (2012) 0.78
Natalizumab treatment decreases serum IgM and IgG levels in multiple sclerosis patients. Mult Scler (2013) 0.78
Aquaporin 4 antibody positive central nervous system autoimmunity and multiple sclerosis are characterized by a distinct profile of antibodies to herpes viruses. Neurochem Int (2010) 0.77
Headaches and pineal cyst: a case-control study. Headache (2007) 0.77
Case scenario: residual curarization in diabetic polyneuropathy. Anesthesiology (2014) 0.76
Is It Too Early to Predict the Failure of Natalizumab in NMO?-Reply. Arch Neurol (2012) 0.76
Impact of the COMT Val(108/158)Met polymorphism on the mu-opioid receptor system in the human brain: mu-opioid receptor, met-enkephalin and beta-endorphin expression. Neurosci Lett (2011) 0.76
A method for low volume and low Se concentration samples and application to paired cerebrospinal fluid and serum samples. J Trace Elem Med Biol (2009) 0.76
18F-labeled sufentanil for PET-imaging of mu-opioid receptors. Bioorg Med Chem Lett (2005) 0.75
Resting tremor in Parkinson disease: is the pallidum to blame? Ann Neurol (2011) 0.75
Multicystic tumor in the fourth ventricle: consider neurocysticercosis. J Neurol (2006) 0.75
Anti-JC-virus antibody prevalence in a German MS cohort. Mult Scler (2012) 0.75
[Key role of endorphins proven for the first time. Jogging really does induce a high! (interview by Dr. Judith Neumaier)]. MMW Fortschr Med (2008) 0.75
Metabolic alterations associated with impaired clock drawing in Lewy body dementia. Psychiatry Res (2010) 0.75
[German Society of Nuclear Medicine procedure guideline on beta-amyloid brain PET imaging]. Nuklearmedizin (2016) 0.75
Neuroimaging Findings Related to Behavioral Disturbances in Alzheimer's Disease: A Systematic Review. Curr Alzheimer Res (2017) 0.75